References for: LACDR-DDS-CTDS

Full identifier: http://purl.org/np/RAdcjjIm7IPqDx73bG45CqnDcWPPhnYQ6cs1d7OSGZGik#LACDR-DDS-CTDS

Nanopublication Part Subject Predicate Object Published By Published On
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
LACDR-DDS-CTDS
(unknown)
2023-07-13T21:28:24.000Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
LACDR-DDS-CTDS
LACDR DDS CTDS | Cancer Therapeutics and Drug Safety, Division of Drug Discovery & Safety, LACDR, Leiden University
(unknown)
2023-07-13T21:28:24.000Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
LACDR-DDS-CTDS
In the Cancer Therapeutics and Drug Safety research group at the LACDR, headed by prof. dr. Bob van de Water, cell signaling programs that underlie adverse drug reactions as well as cancer development and progression are unraveled.
(unknown)
2023-07-13T21:28:24.000Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
LACDR-DDS-CTDS
(unknown)
2023-07-13T21:28:24.000Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
LACDR-DDS-CTDS
(unknown)
2023-07-13T21:28:24.000Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
LACDR-DDS-CTDS
(unknown)
2023-07-13T21:28:24.000Z
links a nanopublication to its pubinfo http://www.nanopub.org/nschema#hasPublicationInfo pubinfo
LACDR-DDS-CTDS
(unknown)
2023-07-13T21:28:24.000Z